文献速递腹部MR

多动脉期MRI显示肝细胞癌风险患者肝脏病灶的动脉期高强化亚型不一致

Multi-arterial phase MRI depicts inconsistent arterial phase hyperenhancement (APHE) subtypes in liver observations of patients at risk for hepatocellular carcinoma.
PubMed 文献 · Eur Radiol · 2021-04-19

回顾性纳入61例肝硬化患者的77个肝脏病灶,5名放射科医师分两阶段阅片,评估多动脉期MRI上动脉期高强化(APHE)亚型的一致性。结果显示,一致判定有APHE的病灶中27.7%同时出现环状和非环状亚型,阅片者间APHE亚型一致性中等(kappa 0.49-0.57),病灶大小对环状APHE一致性有边缘效应(p=0.052)。

要点

  • 约28%的病灶在多动脉期MRI上APHE亚型不一致,可能影响LI-RADS分类。
  • 小病灶的APHE亚型判读更具挑战性。
  • 阅片者间APHE亚型一致性为中等水平(kappa 0.49-0.57)。

关键影像表现/征象

  • 一致判定有APHE的病灶中,27.7%在多动脉期MRI上同时显示环状和非环状APHE亚型。
  • 小病灶对环状APHE的阅片者一致性有边缘水平影响(p=0.052)。

诊断标准与关键数值

  • APHE亚型判读的阅片者间一致性kappa值范围为0.49(95%CI: 0.33, 0.64)至0.57(95%CI: 0.40, 0.74)。
  • 病灶大小对环状APHE一致性的影响p=0.052(趋势水平)。

临床应用与阅片要点

  • 日常阅片需注意多动脉期MRI上APHE亚型可能不一致,尤其小病灶。
  • APHE亚型不一致可能影响LI-RADS分类,报告时应谨慎。

局限性

  • 回顾性研究设计。
  • 样本量较小(61例患者、77个病灶)。
  • 单中心研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: According to LI-RADS, a major discriminating feature between hepatocellular carcinoma (HCC) and non-HCC malignancies is the subtype of arterial phase hyperenhancement (APHE). The aim of this study was to investigate whether APHE subtypes are consistent across multi-arterial phase (mHAP) MRI acquisitions while evaluating reader agreement. Secondarily, we investigated factors that may affect reader agreement for APHE subtype.

METHODS: In this retrospective study, consecutive patients with liver cirrhosis and focal observations who underwent mHAP were included. Five radiologists reviewed MR images in 2 reading sessions. In reading session 1, individual AP series were reviewed and scored for presence of APHE and subtype. In reading session 2, readers scored observations' major and ancillary features and LI-RADS category in the complete MRI examination. Reader agreement was calculated using Fleiss' kappa for binary outcomes and Kendall's coefficient of concordance for LI-RADS categories. Univariate mixed effects logistic regressions were performed to investigate factors affecting agreement.

RESULTS: In total, 61 patients with 77 focal observations were analyzed. Of observations unanimously scored as having APHE, 27.7% showed both rim and nonrim subtypes on mHAP. Inter-reader agreement for APHE subtype ranged from 0.49 (95% CI: 0.33, 0.64) to 0.57 (95% CI: 0.40, 0.74) between reading sessions. Observation size had a trend level effect on rim APHE agreement (p = 0.052).

CONCLUSION: Approximately 1/3 of observations demonstrated inconsistent APHE subtype during mHAP acquisition. Small lesions were particularly challenging. Further guidance on APHE subtype classification, especially when applied to mHAP, could be a focus of LI-RADS refinement.

KEY POINTS: • In a cohort of patients at risk for HCC, 28% of the observations showed inconsistent arterial phase hyperenhancement (APHE) subtypes (rim and nonrim) on multi-arterial phase imaging according to the majority score of 5 independent readers. • Inconsistent APHE subtypes may challenge reliable imaging diagnosis, i.e., LI-RADS categorization, of focal liver observations in patients at risk for HCC.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Cunha GM, Hasenstab KA, Delgado T, et al. Multi-arterial phase MRI depicts inconsistent arterial phase hyperenhancement (APHE) subtypes in liver observations of patients at risk for hepatocellular carcinoma. Eur Radiol. 2021. PMID: 33876298. doi:10.1007/s00330-021-07924-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。